EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Ligilactobacillus salivarius CECT5713 Increases Term Pregnancies in Women with Infertility of Unknown Origin: A Randomized, Triple-Blind, Placebo-Controlled Trial

Cristina Huerga López iD, María J Sánchez Martín iD, Aránzazu Herráez Moreta iD, Marta Calvo Urrutia, Ignacio Cristóbal García iD, Cristina Díaz Morillo, Ruth Blanco-Rojo iD, María E Sáez iD, Mónica Olivares, Rebeca Arroyo, Carmen Herranz, Claudio Alba iD und 2 weitere

Nutrients · 2025

DOI: 10.3390/nu17111860 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, 2025. Verfasst von Cristina Huerga López und 13 weiteren Autor:innen. Beteiligte Einrichtung: Hospital Clínico San Carlos, 28040 Madrid, Spain. Hauptthemen laut MEDLINE: Probiotics, Infertility, Female, Lactobacillus. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kerry Group (Spain), Kerry and the Complutense University of Madrid, Centre for the Development of Industrial Technology (CDTI).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Unexplained infertility is a worldwide problem affecting a significant proportion of couples of reproductive age. Recent studies suggest that alterations in the vaginal microbiota are related to female infertility, while supplementation with some probiotic strains has been shown to improve pregnancy rates in couples experiencing this problem. This study aimed to evaluate the impact of oral administration of Ligilactobacillus salivarius CECT5713 on pregnancy success rates in couples with unexplained infertility prior to in vitro fertilization (IVF).

Methods

Seventy couples were randomized to receive either a placebo or a probiotic intervention (one capsule per day containing an excipient only or 3 × 109 viable cells of L. salivarius CECT5713 plus an excipient, respectively); 57 couples completed the study. Baseline data on demographics, health status (including gynecological and reproductive history), and lifestyle habits were collected. Vaginal swabs and semen samples were obtained from each couple before the intervention and immediately prior to IVF or upon confirmed pregnancy and were analyzed for microbiological (using both culture-dependent and -independent methods) and immunological profiles.

Results

Oral administration of L. salivarius CECT5713 in couples with unexplained infertility scheduled for IVF resulted in a significantly higher pregnancy success rate (48.1%) compared to the placebo group (20.0%) (one-tailed Chi-square test; p < 0.024). The probiotic intervention improved both vaginal and semen immunological profiles, with no substantial changes observed in their microbial composition.

Conclusions

These preliminary findings support the potential of L. salivarius CECT5713 supplementation to enhance fertility outcomes in couples with unexplained infertility.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProbioticsInfertility, FemaleLactobacillusHumansFemalePregnancyAdultVaginaPregnancy RateFertilization in VitroMaleDouble-Blind MethodAdministration, Oral

Stichwörter der Autor:innen

Ligilactobacillus salivariusTGFβ1VEGFassisted reproduction techniquesinfertilityprobioticssemen microbiotavaginal microbiota

Autor:innen und Institutionen

  • Hospital Clínico San Carlos, 28040 Madrid, Spain.
  • Kerry Group, Camino de Purchil 66, 18004 Granada, Spain.
  • Department of Nutrition and Food Science, Complutense University of Madrid, 28040 Madrid, Spain.
  • Instituto Pluridisciplinar, Complutense University of Madrid, 28040 Madrid, Spain.
  • Department of Galenic Pharmacy and Food Technology, Complutense University of Madrid, 28040 Madrid, Spain.

ORCID-Profile: Cristina Huerga López, María J Sánchez Martín, Aránzazu Herráez Moreta, Ignacio Cristóbal García, Ruth Blanco-Rojo, María E Sáez, Claudio Alba, Juan M Rodríguez, Leonides Fernández

Förderung

  • Kerry Group (Spain)
  • Kerry and the Complutense University of Madrid
  • Centre for the Development of Industrial Technology (CDTI)
  • European Regional Development Fund (ERDF)

Zitieren

APA

Huerga López, C., Sánchez Martín, M. J., Herráez Moreta, A., Calvo Urrutia, M., Cristóbal García, I., Díaz Morillo, C., Blanco-Rojo, R., Sáez, M. E., Olivares, M., Arroyo, R., Herranz, C., Alba, C., Rodríguez, J. M., & Fernández, L. (2025). Ligilactobacillus salivarius CECT5713 Increases Term Pregnancies in Women with Infertility of Unknown Origin: A Randomized, Triple-Blind, Placebo-Controlled Trial. Nutrients. https://doi.org/10.3390/nu17111860

Vancouver

Huerga López C, Sánchez Martín MJ, Herráez Moreta A, Calvo Urrutia M, Cristóbal García I, Díaz Morillo C, et al. Ligilactobacillus salivarius CECT5713 Increases Term Pregnancies in Women with Infertility of Unknown Origin: A Randomized, Triple-Blind, Placebo-Controlled Trial. Nutrients. 2025. doi:10.3390/nu17111860

BibTeX
@article{HuergaLpez2025,
  author = {Huerga López, Cristina and Sánchez Martín, María J and Herráez Moreta, Aránzazu and Calvo Urrutia, Marta and Cristóbal García, Ignacio and Díaz Morillo, Cristina and Blanco-Rojo, Ruth and Sáez, María E and Olivares, Mónica and Arroyo, Rebeca and Herranz, Carmen and Alba, Claudio and Rodríguez, Juan M and Fernández, Leonides},
  title = {Ligilactobacillus salivarius CECT5713 Increases Term Pregnancies in Women with Infertility of Unknown Origin: A Randomized, Triple-Blind, Placebo-Controlled Trial},
  journal = {Nutrients},
  year = {2025},
  doi = {10.3390/nu17111860}
}
Kostenlos starten →